Morten Herholdt

Stock Analyst

(n/a)
# 4,638
Out of 4,641 analysts
16
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Morten Herholdt

Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230$225
Current: $189.51
Upside: +18.73%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339$342
Current: $185.90
Upside: +83.97%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $88.16
Upside: -21.73%
Johnson & Johnson
Apr 18, 2024
Upgrades: Buy
Price Target: $169$170
Current: $163.45
Upside: +4.01%
bluebird bio
Mar 5, 2024
Maintains: Reduce
Price Target: $2.31$1.02
Current: $0.51
Upside: +101.70%
Labcorp Holdings
Sep 6, 2023
Initiates: Hold
Price Target: $210
Current: $220.51
Upside: -4.77%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $569.86
Upside: -5.24%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $53.33
Upside: -2.49%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $228.30
Upside: +13.89%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $319.66
Upside: +0.11%
Initiates: Buy
Price Target: $12
Current: $1.88
Upside: +517.02%